Introduction
Dendritic cell (DC) differentiation is tightly regulated by the coordination of signal transduction pathways and transcriptional networks. Fms-like tyrosine kinase-3 (Flt3), macrophage colony-stimulating factor (M-CSF) receptor, and granulocyte macrophage-colonystimulating factor (GM-CSF)-a receptor play major roles in DC development.
1 GM-CSF can derive DCs from murine bone marrow (BM) or human monocytes in vitro [2] [3] [4] and plays essential roles in generating tumor necrosis factor-a-producing DCs and inducible nitric oxide synthase-producing DCs in infection. 5 However, deletion of the GM-CSF receptor gene in mice does not result in a severe reduction of DCs, 6 which implies a redundant role of GM-CSF in DC development. In contrast, Flt3 ligand (Flt3L) is an indispensable cytokine in steady-state DC development; Flt3L induces both conventional DC (cDC) and plasmacytoid DCs (pDCs) development from murine BM, whereas GM-CSF generates only cDCs in vitro. 5, 7, 8 Flt3 and Flt3L knockout (KO) studies showed a dramatic reduction in the number of DCs in mice. [9] [10] [11] Furthermore, BM progenitor cells gain DCdifferentiating potential along with the Flt3 expression in DC progenitors and precursors. 12, 13 Therefore, Flt3L-Flt3 is a dominant cytokine stimuli and signaling network for steady state DC development.
Epigenetic factors play pivotal roles in controlling lineage-specific gene expression in hematopoiesis. A histone deubiquitinase, Mysm1, has been reported in regulating gene expression by interacting with histone acetylase p300/CBP-associated factor (PCAF) and promoting H1 dissociation from nucleosomes that is often linked with gene activation. 14 Recently, we reported the role of Mysm1 in B-cell development and natural killer cell maturation by derepressing expression of transcription. 15, 16 Furthermore, Nijnik et al 17 demonstrated the role of Mysm1 in maintaining BM hematopoietic stem cell (HSC) function and development of lymphoid and erythroid lineages. However, the cellular and physiological functions of Mysm1 are still largely unknown.
In this study, we demonstrated the essential role of histone H2A deubiquitinase Mysm1 in steady state DC development. We showed that Mysm1 regulates the expression of Flt3 by altering histone modifications at its encoding locus and recruiting the transcription factor PU.1 to the promoter region, which contributes to DC lineage specification from common myeloid progenitor (CMP).
Methods

Generation of Mysm1
2/2 mice experiments were approved and performed in accordance with the University of Southern California Institutional Animal Care and Use Committee.
Flow cytometry (FACS) and cell sorting
Sample preparation, cytometric analysis, and cell sorting were performed as described previously. 18, 19 For each staining, at least 100 000 events were collected for analysis. For sorting of the Lin -progenitor population, cells from BM were first depleted of mature hematopoietic cells using a lineage cell depletion kit (Miltenyi Biotec), then sorted by a fluorescence-activated cell sorter (FACS) using the anti-mouse lineage cocktail. More details are included in the supplemental Methods on the Blood Web site.
Chromatin immunoprecipitation
Chromatin was immunoprecipitated according to the manufacturer's instructions (#9002; Cell Signaling). Briefly, sorted cells were crosslinked with 1% formaldehyde and blocked with glycine. Cells were then washed and digested by micrococcal nuclease. The nuclear pellet was suspended in chromatin immunoprecipitation (ChIP) buffer and sheared by sonication. The sheared chromatin was then incubated with various antibodies, uH2A (05-678), H3K27me3 (ab-6002), PU.1 (T-21, sc-352), Mysm1, or control anti-IgG (Cell Signaling), bound to protein A/G plus agarose beads. The immunoprecipitated chromatins were then eluted with ChIP elution buffer. The DNA fragments were released by treatment of ribonuclease A and then proteinase K at 65°C for 2 hours. The released DNA fragments were purified with columns and amplified by site-specific primers by quantitative polymerase chain reaction (qPCR). For sequential 2-step ChIP experiments, 20 crosslinked chromatin was immunoprecipitated with anti-Mysm1 or control IgG (#9002; Cell Signaling) and was then eluted in a solution of 30 mM dithiothreitol, 500 mM NaCl, and 0.1% sodium dodecyl sulfate. Eluted chromatin was reimmunoprecipitated with anti-Pu.1 or control IgG. The binding capability was expressed as a ratio of immunoprecipitated DNA to that in the input sample. The ratio of IgG-precipitated DNA to that in the input sample was set as 1. Primer sequences are available upon request.
Lentivirus and retrovirus production and transduction
Recombinant lentiviral vectors were generated as described. 21 293T cells were cotransfected with package plasmids VSVg, Rev, Gag/Pol, and a recombinant lentiviral vector expressing Mysm1-enhanced green fluorescent protein (eGFP) (LV-Mysm1) or lentiviral vector expressing eGFP (LV-GFP) for recombinant lentiviral production. Retroviruses were produced as previously described. 15 Phoenix cells were transfected with recombinant plasmid pMIG-Flt3-IRES-GFP (pMIG-Flt3) 22 or pMIG-GFP. The pMIGFlt3 was a gift from Dr Stephen L. Nutt (The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia). For transduction, hematopoietic cells seeded in the RetroNectin (TaKaRa)-pretreated culture dishes were added with lentiviral or retroviral supernatants and centrifuged at 3000 rpm for 90 minutes and were then incubated at 37°C in the presence of polybrene (4 mg/mL) for an additional 48 hours.
BM-derived DC culture
Murine BM-derived DCs were prepared as previously described. 19 Briefly, murine BM was flushed from the hind limbs and depleted of red blood cells with red blood cell lysis buffer (#555899; BD Bioscience). After extensive washing with RPMI-1640, cells were cultured with RPMI-1640 supplemented with 20 ng/mL of GM-CSF and IL-4 (PeproTech) or 100 ng/mL of Flt3L (eBioscience). For GM-CSF culture, the culture media were changed every other day until day 7. For Flt3L culture, the cells were cultured for 8 days without disruption.
Statistics
Groups of 3 to 8 mice were used for statistical analysis. P values were calculated using the Student t test.
Results
Mysm1 is required for cDC and pDC development
Our previous studies showed that Mysm1 2/2 mice had overall decreased cellularity in the BM, spleen, and thymus, which resulted from the impaired HSC maintenance and self-renewal. 15 To further define development of myeloid cell lineages in Mysm1 2/2 mice, several hematopoietic organs including the BM and spleen were harvested from 4-to 6-week-old Mysm1 2/2 or wild-type (WT)
littermates, and the development of myeloid populations including DCs, macrophages, and granulocytes were analyzed by FACS ( Figure 1A -H). Both cDC (CD11c hi MHCII 1 ) and pDC (CD11c mid PDCA1 1 ) ( Figure 1A ) were significantly decreased in frequency as well as in absolute number in the spleens of Mysm1 2/2 mice ( Figure 1B ). The proportions of splenic cDC subsets, CD8 1 and CD8 2 cDCs, were not significantly changed ( Figure 1A -B). Since pDCs fully develop in BM and migrate to lymphoid organs, we analyzed the development of pDCs in BM ( Figure 1C-D) . The results showed a significant reduction in the absolute number as well as in the frequency of pDCs in Mysm1 
Intrinsic role of Mysm1 in DC development
To test whether the defect in DC development in Mysm1 (including cDC and pDC), whereas GM-CSF generates only cDCs in vitro. 8, 23 To further examine the intrinsic role of Mysm1 in DC differentiation, BM cells from Mysm1 2/2 and WT littermates were cultured in Flt3L-or GM-CSF/IL-4-supplemented media and DC differentiation was analyzed by FACS. Strikingly, Mysm1 2/2 BM failed to generate cDC (CD11c
), instead, it differentiated into an undefined population with a granulocyte-like phenotype (side scatter/forward scatter high ) upon Flt3L stimulation ( Figure 2B ). In contrast, Mysm1 2/2 BM was able to differentiate into DCs upon GM-CSF/IL4 stimulation ( Figure 2C ). To confirm that the failure of Mysm1 2/2 BM in Flt3L-induced DC culture results from an absence of Mysm1, we reconstituted Mysm1 expression in Mysm1 2/2 BM cells using a recombinant lentiviral Figure 4A ) or GM-CSF/IL-4-supplemented media ( Figure 4B ). We found that deletion of Mysm1 abolished DC generation from all of the precursors tested in Flt3L culture. In contrast, Mysm1 2/2 DC precursors generated DC upon GM-CSF/IL4 stimulation, albeit with less efficiency compared with WT DC precursors ( Figure 4C ), which was likely due to impaired stem cell maintenance and self-renewal. These data indicate that Mysm1 is required for Flt3-induced DC development from early stage of hematopoiesis.
Mysm1 upregulates expression of Flt3 through direct binding at the promoter locus
Expression of Flt3 is essential for steady-state DC development.
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Flt3 is used as a surface marker to identify DC-committed progenitors 26 including CDP, MDP, and pre-cDC given their high expression of Flt3. Our results revealed that Mysm1 2/2 mice genomic sequences of Flt3 from dog, human, monkey, and mouse were aligned, and primers were designed from highly conserved regions including the promoter (promoter 1 and promoter 2) and the first exon (Exon) ( Figure 5C ). Mysm1-chromatin complex was immunoprecipitated by anti-Mysm1 followed by qPCR analysis with site-specific primers. We found that the signal was highly enriched at the Flt3 promoter site ( Figure 5D ), indicating a direct Mysm1 binding at the Flt3 promoter. We have shown that development of macrophage and granulocyte was not as severely affected by deleting Mysm1 as DC development (Figure 1 ), although they all differentiate from CMP. The CMP is a heterogeneous population in which Flt3 expression level varies. A previous report showed that Flt3 1 CMPs give rise to DC progenitors including MDPs and CDPs, whereas Flt3 2 CMPs possess GMP potential that differentiates into macrophages and granulocytes. 13 As shown in Figure 5 , Mysm1 regulates Flt3 expression via a direct association with its promoter region. Therefore, we hypothesized that Mysm1 may induce DC lineage specification from CMPs by upregulating Flt3 expression. To test Figure 5H ). The results demonstrate that Mysm1 plays an important role in DC lineage specification from CMPs by positively regulating Flt3 expression.
Mysm1 regulates modifications of histone, RNA polymerase activity at the Flt3 promoter region
Given that Mysm1 has histone deubiquitinase activity, we hypothesized that the histone ubiquitination status may be altered at the Flt3 promoter site in Mysm1 2/2 . We immunoprecipitated the uH2A-chromatin complex from WT or Mysm1 2/2 BM with an anti-uH2A
antibody, and enrichments in promoter sites, the first exon, and promoter desert region were compared ( Figure 6A) . A significant increase of uH2A was found at both the promoter and promoter desert regions of Flt3 in Mysm1 2/2 BM. Since the ubiquitination status on histones affects other histone modifications, 27, 28 we tested the status of other histone modifications at the Flt3 regulatory locus by ChIP assay. Figure 6B shows a significant increase of repressive trimethylated histone H3 at lysine 27 (H3K27me3) at the Flt3 promoter sites. Previous reports demonstrated that histones act as a restraint for poised RNA polymerase II on gene promoters and a block for transcriptional elongation. 20, 29 RNA polymerase II assembled at the promoter is phosphorylated at serine 5 (S5) of the carboxy-terminal domain repeat through transcription factor IIH. As elongation proceeds, the level of phosphorylation of the carboxy-terminal domain at serine 5 decreases and phosphorylation at serine-2 (S2) increases. 30 To examine activity of RNA polymerase II at the Flt3 promoter, we pulled down chromatin by antibodies that recognize RNA polymerase II with either the S2 or S5 and measured enrichment of Flt3 promoter DNA by qPCR. The level of S2 RNA polymerase II remained similar in WT and Mysm1 2/2 ( Figure 6C ), but we observed an accumulation of S5 RNA polymerase II at the Mysm1 2/2 Flt3 promoter site ( Figure 6D ). This result suggests that an increase of uH2A may cause RNA polymerase to halt at the promoter, which, in turn, blocks it from proceeding to elongation. Collectively, these data suggest that Mysm1 derepresses Flt3 transcription by downregulating the level of uH2A and H3K27me3, thereby promoting transcription elongation at the promoter.
Mysm1 is required for the recruitment of PU.1 to the Flt3 locus, but not to the GM-CSF-a receptor and M-CSF receptor loci PU.1 has been proposed as a crucial regulator of DC development.
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A recent study reported that PU.1 activates expression of Flt3 by directly associating with the Flt3 promoter region. 22 We tested the functionality of Mysm1 on the activating transcription of Flt3 by luciferase reporter assay. The results showed that Mysm1 enhances Flt3 promoter activity (2800 to 144) and PU.1 synergized activity of Mysm1 (supplemental Figure 1 ). Next, we tested whether deletion of Mysm1 affects PU.1 recruitment to the Flt3 promoter by comparing PU.1 occupancy at the Flt3 locus in WT and Mysm1 2/2 BM via ChIP assay. Figure 7A shows that recruitment of PU.1 was significantly decreased at the Flt3 promoter in Mysm1 2/2 . Because both Mysm1 and PU.1 directly bind to the Flt3 promoter region, we examined if there is an interaction between Mysm1 and PU.1 at the Flt3 promoter by sequential 2-step ChIP assay. For the first ChIP, crosslinked chromatin from WT Lin 2 cells was immunoprecipitated with an anti-Mysm1 antibody or a control IgG. The precipitated chromatin was eluted, reimmunoprecipitated with anti-Pu.1 or control IgG (second ChIP) and the precipitated DNA was amplified by primers encompassing the Flt3 promoter by qPCR. The results showed that anti-Pu.1 antibody specifically precipitated the DNA fragment spanning from 20.8 Kb to 0 of the Flt3 promoter that was precipitated by antiMysm1 antibody, implying that Mysm1 and PU.1 occupy the same Flt3 locus ( Figure 7B ). Coimmunoprecipitation assay supported a direct interaction between Mysm1 and PU.1 ( Figure 7C ). PU.1 is a central regulator of many hematopoietic cell lineages and is essential for final differentiation of myeloid cells. 35 Both the GM-CSF-a receptor and M-CSF receptor are required for macrophage and granulocyte development from myeloid progenitors, and their expressions are also activated by direct binding of PU.1 to the promoter loci. 36, 37 Because Mysm1 is found to mediate PU.1 For personal use only. on April 14, 2017 . by guest www.bloodjournal.org From recruitment to the Flt3 promoter, we speculated that Mysm1 may also involve in recruiting PU.1 to the GM-CSF-a receptor and M-CSF receptor promoter loci. To test this hypothesis, we first examined binding of PU.1 and Mysm1 at the promoter regions of GM-CSF-a receptor and M-CSF receptor by ChIP analysis in WT Lin 2 cells. The results showed high enrichment of both GM-CSF-a receptor and M-CSF receptor promoters from the anti-PU.1 pull-down samples, whereas no signal was found from anti-Mysm1 pull-down samples ( Figure 7D ). To further confirm that Mysm1 does not affect PU.1 recruitment to the GM-CSF-a receptor and M-CSFR promoters, chromatin from Mysm1 2/2 BM Lin 2 cells was pulled down by anti-PU.1 antibody or IgG control and precipitation of GM-CSF-a receptor and M2CSF receptor promoters was surveyed by sitespecific primers. The result showed high associations of PU.1 at GM-CSF-a receptor and M-CSF receptor promoters in the absence of Mysm1 ( Figure 7E ). In addition, we observed mRNA expression levels of the GM-CSF-a receptor and the M-CSF receptor was intact in Mysm1 2/2 Lin 2 cells ( Figure 7F) . Collectively, the results indicate that PU.1 recruitment to the GM-CSF-a receptor and M-CSF receptor loci is Mysm1-independent. This data may provide a molecular basis for the selective regulatory mechanism of Mysm1 for DC lineage specification from CMP.
Discussion
Hematopoietic lineage commitment requires both temporal and spatial regulation of gene expression. 38 One of the mechanisms to regulate gene expression is epigenetic control via histone modifications. In this study, we have demonstrated for the first time the essential role of histone H2A deubiquitinase Mysm1 in DC development by derepressing Flt3 transcription.
We found that Mysm1 deletion caused defective DC development in a cell-intrinsic manner. We found further that Mysm1 2/2 BM was unresponsive to Flt3L stimulation, whereas GM-CSF stimulation caused normal DC development in vitro. This data strongly supports the role of Mysm1 in steady-state DC development, because The selective role of Mysm1 in DC differentiation is further supported by PU.1 dependency on Mysm1 for recruitment to the Flt3 loci. Pu.1 is a critical transcription factor in hematopoietic lineage determination and modulates expression of nearly 3000 genes expressed in hematopoietic cells including cell-surface proteins (CD11b) cytokines, and their receptors (granulocyte-CSF, GM-CSF, M-CSF, and Flt3). 11, 36, 41 In our study, we showed that Mysm1 mediates PU.1 recruitment to the Flt3 locus for its transcription, but recruitment of PU.1 to the GM-CSF-a receptor and M-CSF receptor loci is Mysm1-indepenent. Moreover, we observed that the reduction of GMP was not as severe as the reduction of DC-committed precursors (CDPs, pre-cDCs) in Mysm1 2/2 mice, presumably because Flt3 expression is dispensable for GMP development. Thus, this study indicates that, in addition to its differential expression in subsets of CMPs, a lineage-specific defect of DC differentiation in Mysm1 2/2 is attained by Mysm1-dependent or Mysm1-independent recruitment of PU.1 to different gene loci. This unexpected finding certainly raises additional questions about how Mysm1 regulates histone modifications and recruitment of transcription factors in a gene-specific manner. One possible scenario is that Mysm1 may find its binding target in a DNA sequencespecific manner because Mysm1 contains a DNA-binding motif in its SWI3, RSC8 and MOIRA domain. The consensus sequence and detailed mechanisms need to be investigated in the future. Besides its distinct roles in hematopoietic cell differentiation, Mysm1 was found to play important roles in HSC renewal and maintenance. 16, 17 Further studies are needed to investigate how Mysm1 plays such diverse roles.
